HBCO Stock Overview
Operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Hofseth BioCare ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr2.70 |
| 52 Week High | kr2.70 |
| 52 Week Low | kr2.70 |
| Beta | 0.62 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -71.82% |
| 5 Year Change | 18.94% |
| Change since IPO | 44.39% |
Recent News & Updates
Recent updates
Shareholder Returns
| HBCO | GB Biotechs | GB Market | |
|---|---|---|---|
| 7D | 0% | 1.3% | 1.0% |
| 1Y | n/a | -19.3% | 6.7% |
Return vs Industry: Insufficient data to determine how HBCO performed against the UK Biotechs industry.
Return vs Market: Insufficient data to determine how HBCO performed against the UK Market.
Price Volatility
| HBCO volatility | |
|---|---|
| HBCO Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 8.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: HBCO has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HBCO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 60 | Jon Odegard | www.hofsethbiocare.com |
Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol, joint, eye, brain, and cardiovascular function; ProGo, a salmon protein hydrolysate powder for treatment of irondeficiency anaemia, irritable bowel syndrome, and sarcopenia; CalGo, a marine calcium powder produced to support cartilage function, joint health, and bone strength; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was incorporated in 2009 and is headquartered in Ålesund, Norway.
Hofseth BioCare ASA Fundamentals Summary
| HBCO fundamental statistics | |
|---|---|
| Market cap | kr1.09b |
| Earnings (TTM) | -kr139.56m |
| Revenue (TTM) | kr134.43m |
8.1x
P/S Ratio-7.8x
P/E RatioIs HBCO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HBCO income statement (TTM) | |
|---|---|
| Revenue | kr134.43m |
| Cost of Revenue | kr121.71m |
| Gross Profit | kr12.72m |
| Other Expenses | kr152.28m |
| Earnings | -kr139.56m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Aug 25, 2023
| Earnings per share (EPS) | -0.35 |
| Gross Margin | 9.46% |
| Net Profit Margin | -103.81% |
| Debt/Equity Ratio | 89.7% |
How did HBCO perform over the long term?
See historical performance and comparison